Submitted Successfully!
To reward your contribution, here is a gift for you: A free trial for our video production service.
Thank you for your contribution! You can also upload a video entry or images related to this topic.
Version Summary Created by Modification Content Size Created at Operation
1
Vivi Li
+ 355 word(s) 355 2020-12-15 07:52:31

Video Upload Options

Do you have a full video?
Send video materials Upload full video

Confirm

Are you sure to Delete?
Yes No
Cite
If you have any further questions, please contact Encyclopedia Editorial Office.
Li, V. F8 Gene. Encyclopedia. Available online: https://encyclopedia.pub/entry/5496 (accessed on 22 July 2024).
Li V. F8 Gene. Encyclopedia. Available at: https://encyclopedia.pub/entry/5496. Accessed July 22, 2024.
Li, Vivi. "F8 Gene" Encyclopedia, https://encyclopedia.pub/entry/5496 (accessed July 22, 2024).
Li, V. (2020, December 24). F8 Gene. In Encyclopedia. https://encyclopedia.pub/entry/5496
Li, Vivi. "F8 Gene." Encyclopedia. Web. 24 December, 2020.
F8 Gene
Edit
This entry is adapted from the peer-reviewed paper https://medlineplus.gov/genetics/gene/f8

Coagulation factor VIII: The F8 gene provides instructions for making a protein called coagulation factor VIII. 

genes

1. Normal Function

Coagulation factors are a group of related proteins that are essential for the formation of blood clots. After an injury, clots protect the body by sealing off damaged blood vessels and preventing further blood loss.

Coagulation factor VIII is made chiefly by cells in the liver. This protein circulates in the bloodstream in an inactive form, bound to another molecule called von Willebrand factor, until an injury that damages blood vessels occurs. In response to injury, coagulation factor VIII is activated and separates from von Willebrand factor. The active protein (sometimes written as coagulation factor VIIIa) interacts with another coagulation factor called factor IX. This interaction sets off a chain of additional chemical reactions that form a blood clot.

2. Health Conditions Related to Genetic Changes

2.1 Hemophilia

Mutations in the F8 gene cause hemophilia A, the most common form of this bleeding disorder. More than 1,300 alterations in this gene have been identified. Some of these mutations change single DNA building blocks (base pairs) in the gene, while others delete or insert multiple base pairs. The most common mutation in people with severe hemophilia A is a rearrangement of genetic material called an inversion. This inversion involves a large segment of the F8 gene.

Mutations in the F8 gene lead to the production of an abnormal version of coagulation factor VIII or reduce the amount of this protein. The altered or missing protein cannot participate effectively in the blood clotting process. As a result, blood clots cannot form properly in response to injury. These problems with blood clotting lead to excessive bleeding that can be difficult to control. Some mutations, such as the large inversion described above, almost completely eliminate the activity of coagulation factor VIII and result in severe hemophilia. Other mutations reduce but do not eliminate the protein's activity, resulting in mild or moderate hemophilia.

3. Other Names for This Gene

  • AHF

  • antihemophilic factor

  • coagulation factor VIII, procoagulant component

  • coagulation factor VIII, procoagulant component (hemophilia A)

  • DXS1253E

  • FA8_HUMAN

  • Factor VIIIF8B

  • FVIII

  • HEMA

  • procoagulant component

References

  1. Bicocchi MP, Pasino M, Lanza T, Bottini F, Boeri E, Mori PG, Molinari AC,Rosano C, Acquila M. Analysis of 18 novel mutations in the factor VIII gene. Br JHaematol. 2003 Sep;122(5):810-7.
  2. Bogdanova N, Markoff A, Eisert R, Wermes C, Pollmann H, Todorova A, ChlystunM, Nowak-Göttl U, Horst J. Spectrum of molecular defects and mutation detectionrate in patients with mild and moderate hemophilia A. Hum Mutat. 2007Jan;28(1):54-60.
  3. Bogdanova N, Markoff A, Pollmann H, Nowak-Göttl U, Eisert R, Wermes C,Todorova A, Eigel A, Dworniczak B, Horst J. Spectrum of molecular defects andmutation detection rate in patients with severe hemophilia A. Hum Mutat. 2005Sep;26(3):249-54.
  4. Bolton-Maggs PH, Pasi KJ. Haemophilias A and B. Lancet. 2003 May24;361(9371):1801-9. Review.
  5. Bowen DJ. Haemophilia A and haemophilia B: molecular insights. Mol Pathol.2002 Apr;55(2):127-44. Review. Erratum in: Mol Pathol 2002 Jun;55(3):208.
  6. Graw J, Brackmann HH, Oldenburg J, Schneppenheim R, Spannagl M, Schwaab R.Haemophilia A: from mutation analysis to new therapies. Nat Rev Genet. 2005Jun;6(6):488-501. Review.
  7. Oldenburg J, El-Maarri O. New insight into the molecular basis of hemophiliaA. Int J Hematol. 2006 Feb;83(2):96-102. Review.
  8. Shen BW, Spiegel PC, Chang CH, Huh JW, Lee JS, Kim J, Kim YH, Stoddard BL. Thetertiary structure and domain organization of coagulation factor VIII. Blood.2008 Feb 1;111(3):1240-7.
  9. Thompson AR. Structure and function of the factor VIII gene and protein. SeminThromb Hemost. 2003 Feb;29(1):11-22. Review.
More
©Text is available under the terms and conditions of the Creative Commons-Attribution ShareAlike (CC BY-SA) license; additional terms may apply. By using this site, you agree to the Terms and Conditions and Privacy Policy.
Upload a video for this entry
Information
Subjects: Genetics & Heredity
Contributor MDPI registered users' name will be linked to their SciProfiles pages. To register with us, please refer to https://encyclopedia.pub/register :
Vivi Li
View Times: 444
Entry Collection: MedlinePlus
Revision: 1 time (View History)
Update Date: 24 Dec 2020
Table of Contents
    1000/1000
    Hot Most Recent
    Video Production Service
    Feedback